Q4 2025 Holdings
Filed 2026-02-17 | 16 holdings | $135.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $44.8M | 2,457,542 | 33.1% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $15.9M | 3,281,501 | 11.7% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $10.6M | 4,500,000 | 7.8% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.9M | 1,800,556 | 7.3% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $9.8M | 33,237 | 7.2% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $7.3M | 920,000 | 5.4% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $7.1M | 400,000 | 5.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $6.3M | 90,000 | 4.6% |
| Assembly Biosciences Inc(ASMB) | COM NEW | 045396207 | $6.0M | 175,706 | 4.4% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $4.1M | 1,500,000 | 3.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.3M | 100,000 | 2.4% |
| Aura Biosciences Inc(AURA) | COM | 05153U107 | $3.1M | 572,576 | 2.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $3.1M | 135,000 | 2.3% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $2.3M | 75,000 | 1.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.5M | 20,000 | 1.1% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $486.0K | 50,000 | 0.4% |